Clinical Trial Update: A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3 [Phase 2]

View source ↗

Summary

Phase II/III randomized trial comparing monotherapy versus combination therapy with nucleoside analogs in HIV-infected individuals with CD4 counts 200-500 cells…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED